Your browser doesn't support javascript.
loading
Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Geck, Renee C; Foley, Jackson R; Murray Stewart, Tracy; Asara, John M; Casero, Robert A; Toker, Alex.
Afiliação
  • Geck RC; Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
  • Foley JR; Harvard Medical School, Boston, Massachusetts 02115.
  • Murray Stewart T; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.
  • Asara JM; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.
  • Casero RA; Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215.
  • Toker A; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287.
J Biol Chem ; 295(19): 6263-6277, 2020 05 08.
Article em En | MEDLINE | ID: mdl-32139506
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Poliaminas Biogênicas / Eflornitina / Citotoxinas / Neoplasias de Mama Triplo Negativas / Inibidores da Ornitina Descarboxilase / Proteínas de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Poliaminas Biogênicas / Eflornitina / Citotoxinas / Neoplasias de Mama Triplo Negativas / Inibidores da Ornitina Descarboxilase / Proteínas de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article